Zhida Liu Selected Research

Zhida Liu Research Topics

Disease

29	Neoplasms (Cancer) 12/2023 - 01/2016
4	Bites and Stings (Sting) 01/2022 - 01/2019
2	Infections 12/2023 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2024
1	COVID-19 12/2023
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Adenocarcinoma of Lung 01/2022
1	Inflammation (Inflammations) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Idiopathic Pulmonary Fibrosis 12/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2015

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2016
5	VaccinesIBA 01/2023 - 06/2016
5	AntigensIBA 01/2022 - 06/2016
3	Interleukin-2 (IL2)IBA 01/2021 - 01/2019
3	B7-H1 AntigenIBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2019
3	InterferonsIBA 01/2021 - 01/2019
3	Therapeutic UsesIBA 01/2020 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2023 - 12/2023
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2023 - 01/2023
2	ProdrugsIBA 01/2023 - 01/2019
2	NanovaccinesIBA 01/2022 - 01/2019
2	Interferon Type IIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	Caspase 9IBA 11/2020 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2017
1	Carbon DioxideIBA 02/2024
1	ethyleneIBA 12/2023
1	Phosphates (Orthophosphate)IBA 12/2023
1	Broadly Neutralizing AntibodiesIBA 12/2023
1	AntibodiesIBA 12/2023
1	Singlet OxygenIBA 01/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Cancer VaccinesIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	InflammasomesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	CaspasesIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	Cetuximab (Erbitux)FDA Link 10/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	DisaccharidesIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	beta-lapachoneIBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 01/2017
1	MicellesIBA 01/2017
1	PlatinumIBA 03/2015
1	Ifosfamide FDA LinkGeneric 03/2015
1	Etoposide (VP 16)FDA LinkGeneric 03/2015

Therapy/Procedure

14	Immunotherapy 12/2023 - 01/2016
12	Therapeutics 01/2022 - 01/2016
4	Radiotherapy 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2016
1	Continuous Renal Replacement Therapy 02/2024
1	Artificial Respiration (Mechanical Ventilation) 02/2024
1	Intravenous Administration 12/2023
1	Subcutaneous Injections 01/2022
1	Precision Medicine 01/2022
1	Radioimmunotherapy 01/2021